WHO cancer pain relief programme
- PMID: 2454740
WHO cancer pain relief programme
Abstract
Cancer pain relief is a ubiquitous but neglected public health problem. Every day more than three and a half million people suffer from cancer pain, but only a fraction receive treatment for it. Relatively simple and inexpensive methods of pain relief are available. Adequate pain relief is not reaching a great number of cancer patients in developed countries. In the developing countries, where more than half the world's cancer patients are and where most are incurable at the time of diagnosis, pain relief (often the only relevant human alternative) by and large is not offered. Obstacles to effective cancer pain relief worldwide include poor drug availability, misguided national drug legislation, lack of education of doctors and nurses, underprescribing and underdosing by the professionals, wrong timing of drugs given, fear of addiction and lack of public awareness that pain can be controlled. A World Health Organization (WHO) method has been developed which provides for drugs to be administered immediately if there is pain, to be given 'by the clock' rather than 'on demand' and to be increased from non-opioids (aspirin or paracetamol) to weak opioids (codeine) and then to strong opioids (morphine) until the patient is free from pain--hence the concept of a three-step ladder for cancer pain relief. Field tests have shown that the right drug in the right dose at the right time relieves 80 to 90% of pain. Thus a scientifically valid, relatively inexpensive method suitable for reaching patients at community level does exist.
Similar articles
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
WHO guidelines for the use of analgesics in cancer pain.Int J Tissue React. 1985;7(1):93-6. Int J Tissue React. 1985. PMID: 2409039
-
[Cancer pain management].Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-1):1031-7. Gan To Kagaku Ryoho. 1989. PMID: 2730006 Japanese.
-
[Chronic pain in cancer patients].Ter Arkh. 1990;62(10):69-71. Ter Arkh. 1990. PMID: 1982195 Russian.
-
The lesson from cancer pain.Eur J Pain. 2000;4 Suppl A:3-7. Eur J Pain. 2000. PMID: 11310480 Review.
Cited by
-
[The specialty of anesthesia outside Western medicine with special consideration of personal experience in the Democratic Republic of the Congo and Mongolia].Anaesthesist. 2006 Feb;55(2):118-32. doi: 10.1007/s00101-006-0979-6. Anaesthesist. 2006. PMID: 16425039 Free PMC article. Review. German.
-
Cobalt Oxide Nanoparticles/Graphene/Ionic Liquid Crystal Modified Carbon Paste Electrochemical Sensor for Ultra-sensitive Determination of a Narcotic Drug.Adv Pharm Bull. 2019 Feb;9(1):110-121. doi: 10.15171/apb.2019.014. Epub 2018 Feb 21. Adv Pharm Bull. 2019. PMID: 31011565 Free PMC article.
-
Recent advances in the use of opioids for cancer pain.J Pain Res. 2009 Sep 23;2:135-55. doi: 10.2147/jpr.s6905. J Pain Res. 2009. PMID: 21197301 Free PMC article.
-
Undertreatment of cancer pain: barriers and remedies.Support Care Cancer. 1993 Mar;1(2):74-8. doi: 10.1007/BF00366899. Support Care Cancer. 1993. PMID: 7511475 Review.
-
Ultrasound-Guided Erector Spinae Plane Block in Emergency Department for Abdominal Malignancy Pain: A Case Report.Clin Pract Cases Emerg Med. 2022 Nov;6(4):314-317. doi: 10.5811/cpcem.2022.3.55752. Clin Pract Cases Emerg Med. 2022. PMID: 36427032 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical